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Abstract
Metabolic alterations including postprandial hyperglycemia have been implicated in the development of obesity-related diseases. Xylose is a sucrase
inhibitor suggested to suppress the postprandial glucose surge. The objectives of this study were to assess the inhibitory effects of two different
concentrations of xylose on postprandial glucose and insulin responses and to evaluate its efficacy in the presence of other macronutrients. Randomized
double-blind cross-over studies were conducted to examine the effect of D-xylose on postprandial glucose and insulin response following the oral
glucose tolerance test (OGTT). In study 1, the overnight-fasted study subjects (n = 49) consumed a test sucrose solution (50 g sucrose in 130 ml
water) containing 0, 5, or 7.5 g D-xylose powder. In study 2, the overnight-fasted study subjects (n = 50) consumed a test meal (50 g sucrose 
in a 60 g muffin and 200 ml sucrose-containing solution). The control meal provided 64.5 g of carbohydrates, 4.5 g of fat, and 10 g of protein. 
The xylose meal was identical to the control meal except 5 g of xylose was added to the muffin mix. In study 1, the 5 g xylose-containing solutions
exhibited significantly lower area under the glucose curve (AUCg) and area under the insulin curve (AUCi) values for 0-15 min (P < 0.0001,  P
< 0.0001), 0-30 min (P < 0.0001,  P< 0.0001), 0-45 min (P< 0.0001,  P < 0.0001), 0-60 min (P< 0.0001,  P< 0.0001), 0-90 min (P < 0.0001,  P<
0.0001) and 0-120 min (P= 0.0071,  P= 0.0016). In study 2, the test meal exhibited significantly lower AUCg and AUCi values for 0-15 min
(P< 0.0001,  P< 0.0001), 0-30 min (P< 0.0001,  P< 0.0001), 0-45 min (P< 0.0001,  P= 0.0005), 0-60 min (P= 0.0002,  P= 0.0025), and 0-90 min
(P= 0.0396,  P= 0.0246). In conclusion, xylose showed an acute suppressive effect on the postprandial glucose and insulin surges. 
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Introduction6)
Obesity has been a major health concern worldwide, and the 
World Health Organization estimated that approximately 1.5 
billion adults were overweight and that over 200 million men 
and nearly 300 million women were obese in 2008. The National 
Health and Nutrition Examination Survey of Korea has also 
reported that 34.0% of the population is either overweight or 
obese, raising a serious health hazard. Major metabolic disturbances 
due to excess body fat include insulin resistance, which is 
characterized by the impeded capacity of peripheral tissues to 
utilize glucose effectively [1], causing hyperglycemia and 
hyperinsulinemia. Increased circulating concentration of insulin 
also result in changes in lipid metabolism, cell growth, and cell- 
to-cell communication [2] which eventually lead to obesity- 
related disease development. 
The glycemic index (GI) was introduced to classify starchy 
foods according to their effect on postprandial glycemia [3]. 
Later, the glycemic load (GL) concept was introduced reflecting 
the quality (GI) and quantity of a specific food consumed that 
affect postprandial glycemic response [4]. Both low GI foods 
and low GL diets have been successfully applied to alleviate 
hyperglycemic and hyperinsulinemic conditions in prediabetic 
and diabetic individuals. Besides GI and GL, a growing body 
of research has focused on functional substances inhibiting 
carbohydrate digestion enzymes [5-6].
Previous preliminary studies have indicated that several 
monosaccharides act as glucosidase inhibitors [7-8]. D-xylose at 
a 10 mmol/L concentration inhibits intestinal sucrase activity by 
52.1% [8]. Rats fed a combination of sucrose (2 g/kg) and xylose 
(0.1 g/kg) solution have significantly reduced postprandial blood 
glucose concentrations at 30 and 60 min compared to those of 
rats fed a sucrose solution alone [9]. One small-scale human study 
(n = 5) showed the efficacy of xylose to suppress the increase 
in postprandial blood glucose in which healthy males showed 
lowered postprandial blood levels glucose and insulin at 30 min 
after consuming the solution containing xylose (7.5 g) mixed 
with, 75 g of sucrose compared to levels after consuming a 100% 
sucrose solution. However, no significant difference was 
observed in blood glucose or insulin concentrations for the 
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remaining time points. Gruzman et al. [10] reported that D-xylose 
increases the rate of glucose transport in a non-insulin-dependent 
manner in rats and human myotubes in vitro. These results 
suggest that xylose may be a good candidate functional food 
to control the postprandial blood glucose and insulin surges and 
possibly alleviate metabolic disturbances.
Previous studies have reported that diet composition particularly 
quantitatively important macronutrients influence postprandial 
glycemia by affecting the rate of carbohydrate digestion and 
absorption. Dietary fat, carbohydrate, and protein in a single meal 
interact with each other to influence the rate of absorption [11]. 
Therefore, digestive enzyme inhibitors such as xylose may act 
differently when they are used as ingredients of specific food products
Thus, the objectives of this study were to assess the inhibitory 
effects of two different concentrations of xylose on postprandial 
serum glucose and insulin concentrations in a large group of 
healthy human subjects and to evaluate its efficacy in the form 
of a food product.
Subjects and Methods
Subjects
Forty-nine subjects (25 males and 24 females) participated in 
study 1. Their average age was 35.4 ± 6.4 years (range, 25-49 
years), and their body mass index was 23.8 ± 3.0 kg/m
2. In study 
2, 50 subjects (24 males and 26 females) participated. Their 
average age was 33.7 ± 6.0 years (range, 25-49 years), and their 
body mass index was 23.9 ± 3.2 kg/m
2. The study subjects were 
recruited from a university website advertisement based on the 
following criteria: (1) fasting serum glucose < 7 mmol/L; (2) 
absence of any disease; (3) under no medications or dietary 
supplements; and (4) non-pregnant women. Thirty subjects (13 
males and 17 females) were enrolled in both studies. This study 
was approved by the Institutional Review Board of Sookmyung 
Women’s University (SM-IRB-11-0217-001), and eligible 
subjects gave informed written consent.
Sample size was calculated based on a previous clinical trial 
[12-14], and a 1.0 mmol/L reduction in the peak glucose 
concentration during the oral glucose tolerance test (OGTT) was 
considered to be the primary efficacy point with the average 
standard deviation (SD) of 1.2 mmol/L at a two-tailed alpha =
0.05 and 1-β =8 0 % .
Study design
Study 1
This study used a randomized double-blind three treatment 
cross-over design. The overnight fasted study subjects visited the 
trial center at the university once per week for 3 weeks and 
consumed a test sucrose solution (50 g sucrose in 130 ml water) 
containing 0, 5, or 7.5 g D-xylose powder each week in random 
order. Xylose concentrations were determined based on a previous 
report in which xylose mixed with sucrose at a 10% level showed 
a delay in glucose absorption [9]. Study subjects were asked to 
maintain their usual dietary and physical activity habits throughout 
the study. No significant differences in nutrient intake were 
observed (by 24-recall method) between visits (data not shown). 
Study 2
Study 2 was conducted as a randomized double-blind two 
treatment cross-over trial. The overnight-fasted study subjects 
visited the trial center once per week for 2 weeks and consumed 
a test meal in a given time (10 min) in random order. The test 
meal consisted of a muffin (60 g) and a sucrose-containing solution 
(200 ml). The control meal provided 64.5 g of carbohydrates 
(sucrose 50 g), 4.5 g of fat, and 10 g of protein. The xylose meal 
was identical to the control meal except 5 g of D-xylose was 
additionally added to the muffin mix. Study subjects were asked 
to maintain their usual dietary habits and physical activity level 
throughout the study. No significant differences in nutrient intake 
were observed (by 24-recall method) between visits (data not 
shown).
Blood analyses
A cannula was placed in the antecubital vein and blood samples 
were taken at the following times: 0, 15, 30, 45, 60, 90, and 
120 minutes after taking the test solution or meal. The samples 
were left at room temperature for 30 min, centrifuged for 15 
min at 2,500 rpm to separate the serum, and then stored at -70℃. 
Serum glucose concentrations were measured using the Pureauto 
S GLU reagent (Daiichi Pure Chemicals, Tokyo, Japan). Insulin 
was measured by electrochemiluminescence immunoassay (Roche 
Diagnostics GmbH, Mannheim, Germany). Serum glucose and 
insulin were measured at every time point (0, 15, 30, 45, 60, 
90, and 120 minutes) after taking the test solution or meal, and 
the blood glycated hemoglobin (HbA1c), serum total cholesterol, 
triglyceride, and high density lipoprotein (HDL)-cholesterol were 
measured at only one time point (0 minutes). Blood HbA1c was 
determined by high performance liquid chromatography. An 
autoanalyzer (Hitachi 747 auto-analyzer, Tokyo, Japan) was used 
to quantify blood concentrations of serum total cholesterol, 
triglyceride, and HDL-cholesterol. Serum low-density lipoprotein 
(LDL) cholesterol concentration was calculated according to the 
Friedewald formula [15].
Calculations and statistical analysis
All results are presented as mean ± SD. The areas under the 
glucose (AUCg) or insulin (AUCi) curves were calculated using 
the trapezoidal rule [16]. Statistical analyses were performed to 
compare the AUC of glucose and insulin and to compare Yun Jung Bae et al. 535
Study 1 Study 2
Age and body composition parameters
Age (yrs) 35.49 ± 6.36
1) 33.68 ± 6.04
Distribution 20‘s 20.41 24.00
(%) 30‘s 59.18 62.00
40‘s 20.41 14.00
Height (cm) 167.65 ± 8.61 166.66 ± 8.39
Weight (kg) 67.45 ± 12.37 66.57 ± 13.82
BMI (kg/m
2) 23.84 ± 3.00 23.85 ± 3.24
Distribution Underweight 0.00 2.00
(%) Normal 42.86 38.00
Overweight 26.53 26.00
Obesity 30.61 34.00
Body fat percent (%) 27.13 ± 6.27 27.37 ± 5.70
Smoking Current (%) 16.33 12.00
Former (%) 16.33 16.00
Never (%) 67.35 72.00
Drinking Current (%) 67.35 66.00
Former (%) 2.04 2.00
Never(%) 30.61 32.00
Clinical parameters
Serum cholesterol (mg/dl) 190.49 ± 29.74 184.38 ± 28.13
Serum triacylglyceride (mg/dl) 110.06 ± 75.17 100.88 ± 56.64
Serum HDL-cholesterol (mg/dl) 53.20 ± 9.51 57.32 ± 13.03
Serum LDL-cholesterol (mg/dl) 115.27 ± 27.36 108.22 ± 26.85
Blood HbA1c (%) 5.56 ± 0.29 5.48 ± 0.28
Serum glucose (mmol/L) 4.99 ± 0.36 4.70 ± 0.35
Serum insulin (pmol/L) 46.78 ± 19.13 39.65 ± 22.7
1) Mean ± SD
Table 1. Age, body composition, and clinical parameters
Fig. 1. Mean serum glucose responses after ingestion of 50 g sucrose with 
5 g (low) xylose, 7.5 g xylose (high), or the control (sucrose). Values  with 
difference  letters  (a,  b)  at  the  same  time  point  are  significantly  different 
(repeated-measure  ANOVA  followed  by  Tukey's  multiple  test,  P < 0.05)  (b < a).
Fig. 2. Mean serum insulin responses after ingestion of 50 g sucrose with 5 
g (low) xylose, 7.5 g xylose (high), or the control (sucrose). Values  with 
difference  letters  (a,  b)  at  the  same  time  point  are  significantly  different 
(repeated-measure  ANOVA  followed  by  Tukey's  multiple  test,  P < 0.05)  (b < a).
concentrations of serum glucose and insulin between treatments 
at each time point. Differences were assessed using repeated-measure 
analysis of variance followed by Tukey’s multiple comparisons 
test (study 1) or Student’s paired t-test (study 2). The two-tailed 
significance threshold was set at P < 0.05. Statistical analyses 
were performed using SAS program version 9.1 (SAS Institute, 
Cary, NC, USA).
Results
Body compositions and clinical parameters of the study 
participants at baseline of each study are shown in Table 1. In 
study 1, the proportion of individuals with dyslipidemia was 
12.2% for cholesterol (reference range, ≥230 mg/dl), 8.2% for 
triglycerides (reference range, ≥200 mg/dl), and 4.1% for 
LDL-cholesterol (reference range, ≥150 mg/dl), and the 
proportion of the impaired fasting glucose individuals was 8.2% 
for glucose (reference range, fasting glucose ≥ 100 mg/dl and 
< 126 mg/dl). In study 2, the proportion of individuals with 
dyslipidemia was 4.0% for cholesterol (reference range, ≥ 230 
mg/dl), 8.0% for triglycerides (reference range, ≥200 mg/dl), 
and 4.0% for LDL-cholesterol (reference range, ≥ 150 mg/dl). 
The proportion of individuals with impaired fasting glucose was 
2.0% for glucose (reference range, fasting glucose, ≥100 mg/dl 
and < 126 mg/dl).
Study 1
The postprandial glucose and insulin responses after ingestion 
of 50 g sucrose with 5 g (low) xylose, 7.5 g xylose (high), or 
control (sucrose only) are presented in Figs. 1 and 2. The 
concentrations of serum glucose at 15 min (P< 0.0001), 30 min 
(P < 0.0001), and 45 min (P = 0.0005) were significantly lower 
after consuming both concentrations of xylose-containing solutions 
compared to those after consuming the control solution. However, 
glucose concentration was significantly higher at 120 min for 
those who consumed the xylose-containing solution (P< 0.0001). 
Serum concentrations of insulin at 15 min (P< 0.0001), 30 min 
(P < 0.0001), and 45 min (P = 0.0001) were also significantly 
lower after consuming both concentrations of xylose-containing 
solution than those after consuming the control solution. 
However, the xylose-containing solution significantly increased 
serum insulin at 120 min (P < 0.0001) compared to that in the 
control solution. No differences were observed for postprandial 
serum glucose or insulin concentration at either 60 or 90 min.
The incremental area under the curve of postprandial serum 
glucose and insulin are shown in Tables 2 and 3. Xylose- 
containing solutions exhibited significantly lower AUCg values 
at 0-15 min (P < 0.0001), 0-30 min (P < 0.0001), 0-45 min (P
< 0.0001), 0-60 min (P < 0.0001), and 0-90 min (P < 0.0001). 
However, the 0-120 min AUCg for in the 5 g xylose-supple-
mented solution was significantly lower than that of the control 
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AUCg (mmolㆍmin/L)
0-15 0-30 0-45 0-60 0-90 0-120
Control 9.79 ± 5.53
1)a2) 35.82 ± 16.32
a 67.57 ± 29.31
a 93.97 ± 44.31
a 122.33 ± 65.64
a 130.90 ± 72.64
a 
Xylose_low 5.16 ± 3.60
b 21.54 ± 10.06
b 43.59 ± 19.17
b 63.59 ± 30.70
b 90.24 ± 48.45
b 102.86 ± 57.57
b 
Xylose_high 5.15 ± 2.98
b 21.42 ± 9.15
b 43.62 ± 17.42
b 64.08 ± 27.46
b 94.64 ± 47.26
b 113.10 ± 57.41
ab
P value < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.0071
1) Mean ± SD
2) Values  sharing  the  same  superscript  letter  (a,  b)  are  not  significantly  different  (repeated-measure  ANOVA  followed  by  Tukey's  multiple  test,  P < 0.05)  (b < a).
AUCg,  area  under  the  glucose  curve 
Table 2. Postprandial serum glucose areas under the curve (AUCs) in subjects after ingestion of 50 g sucrose with 5 g xylose (low), 7.5 g xylose (high), or control
(sucrose) in each group
AUCi (pmolㆍmin/L)
0-15 0-30 0-45 0-60 0-90 0-120
Control 957.24 ± 634.40
1)a2) 3,475.05 ± 1,953.45
a 6,368.78 ± 3,531.75
a 8,850.01 ± 5,086.11
a 12,253.87 ± 7,538.91
a 13,935.51 ± 8,368.30
a 
Xylose_low 524.38 ± 433.65
b 2,094.55 ± 1,338.18
b 4,128.41 ± 2,353.77
b 6,137.15 ± 3,220.07
b 9,250.09 ± 4,490.77
b 10,966.68 ± 5,091.73
b 
Xylose_high 518.43 ± 403.38
b 1,949.95 ± 1,333.16
b 3,757.90 ± 2,398.40
b 5,516.01 ± 3,432.93
b 8,635.25 ± 5,234.36
b 10,785.92 ± 6,149.17
b 
P value < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.0016
1) Mean ± SD
2) Values  sharing  the  same  superscript  letter  (a,  b)  are  not  significantly  different  (repeated-measure  ANOVA  followed  by  Tukey's  multiple  test,  P < 0.05)  (b < a).
AUCi,  area  under  the  insulin  curve 
Table 3. Postprandial serum insulin areas under the curve (AUCs) in subjects after ingestion of 50 g sucrose with 5 g xylose (low), 7.5 g xylose (high), or control
(sucrose) in each group
Fig. 3. Mean serum glucose responses after ingestion of the control and test 
meal. Time points with a P-value indicate a significant difference between the two 
tests.
     Fig. 4. Mean serum insulin responses after ingestion of the control and test 
meal. Time points with a P-value indicate a significant difference between the two 
tests.
xylose supplementation compared to those of the control were 
47.3% (0-15 min), 39.9% (0-30 min), 35.5% (0-45 min), 32.3% 
(0-60 min), 26.2% (0-90 min), and 21.4% (0-120 min), respectively. 
Both 5 and 7.5 g xylose supplementation significantly reduced 
postprandial AUCi at 0-15 min (P < 0.0001), 0-30 min (P <
0.0001), 0-45 min (P< 0.0001), 0-60 min (P< 0.0001), 0-90 min 
(P< 0.0001), and 0-120 min (P= 0.0016). The percent decreases 
in AUCi with 5g xylose supplementation compared to those of 
the control were 45.2% (0-15 min), 39.2% (0-30 min), 35.2% 
(0-45 min), 30.7% (0-60 min), 24.5% (0-90 min), and 21.3% 
(0-120 min), respectively.
Study 2
The mean postprandial serum glucose and insulin responses 
after ingestion of either the control meal or test meal are 
presented in Figs. 3 and 4. The concentrations of serum glucose 
at 15 min (P < 0.0001) and 30 min (P < 0.0001) after intake of 
the test meal were significantly lower than those after intake of 
the control meal. Additionally, the concentrations of insulin at 
15 min (P< 0.0001) and 30 min (P= 0.0136) after intake of the 
test meal were significantly lower than those after intake of the 
control meal. No differences were observed for postprandial serum 
glucose or insulin concentrations at 45, 60, 90, or 120 min.
The incremental area under the curve of postprandial serum 
glucose and insulin are shown in Tables 4 and 5. The test meal 
significantly lowered AUCg values at 0-15 min (P < 0.0001), 
0-30 min (P < 0.0001), 0-45 min (P < 0.0001), 0-60 min (P =
0.0002), and 0-90 min (P = 0.0396). The percent decreases in 
AUCg with the test meal compared to those of the control meal 
were 37.0% (0-15 min), 32.4% (0-30 min), 26.5% (0-45 min), 
21.4% (0-60 min), and 12.8% (0-90 min), respectively. The test 
meal significantly reduced postprandial AUCi at 0-15 min (P
< 0.0001), 0-30 min (P < 0.0001), 0-45 min (P = 0.0005), 0-60 
min (P = 0.0025), and 0-90 min (P = 0.0246). The percent 
decreases in AUCi with a test meal compared to those of the 
control meal were 47.8% (0-15 min), 39.5% (0-30 min), 32.7% 
(0-45 min), 28.9% (0-60 min), and 21.5% (0-90 min), respectively.Yun Jung Bae et al. 537
AUCg (mmol․min/L)
0-15 0-30 0-45 0-60 0-90 0-120
Control meal  14.25 ± 6.12
1) 49.45 ± 17.25  86.86 ± 29.51  114.42 ± 41.82 146.47 ± 58.20 163.28 ± 65.60 
Test meal  8.98 ± 3.50  33.42 ± 9.95  63.81 ± 20.08  89.92 ± 34.24  127.68 ± 59.09  152.33 ± 71.94 
P value < 0.0001 < 0.0001 < 0.0001 0.0002 0.0396 0.2757
1) Mean ± SD
AUCg,  area  under  the  glucose  curve 
Table 4. Postprandial serum glucose areas in the subjects after ingestion of the control and test meals
AUCi (pmol․ min/L)
0-15 0-30 0-45 0-60 0-90 0-120
Control meal  1,698.47 ± 1,212.73
1) 5,572.97 ± 3,757.34 9,786.32 ± 6,461.65  13,609.46 ± 8,674.86  19,453.64 ± 11,799.30  23,338.98 ± 13,887.11 
Test meal  886.95 ± 567.83  3,373.09 ± 1,903.69  6,584.93 ± 3,633.96  9,678.11 ± 5,456.76  15,272.46 ± 9,313.13  19,801.82 ± 12,456.79 
P value < 0.0001 < 0.0001 0.0005 0.0025 0.0246 0.1095
1) Mean ± SD
AUCi,  area  under  the  insulin  curve 
Table 5. Postprandial serum insulin areas in the subjects after ingestion of the control and test meal
Discussion
Two acute randomized double-blind cross-over studies were 
conducted to examine the effect of D-xylose on postprandial 
glucose and insulin responses following an OGTT. Xylose is 
classified as a monosaccharide of the aldopentose type containing 
five carbon atoms and an aldehyde functional group. It is a 
precursor to hemicellulose, one of the main constituents of 
biomass. Corn cob, coconut, seed hulls, and straw are rich sources 
of D-xylose. D-xylose has been suggested as a potent sucrase 
inhibitor possibly by suppressing the postprandial glucose surge; 
however, no concrete scientific evidence has been provided for 
its efficacy in humans. 
Recent statistics indicate that a growing number of the 
population are either overweight or obese due to excess dietary 
energy intake, which promotes create insulin resistance. Evidence 
suggests that the initial pathophysiological changes during the 
progress of type 2 diabetes, cardiovascular heart diseases, and 
cancer are closely related to hyperinsulinemia, which lead to 
metabolic dysregulation. Post-challenge glucose levels of 108 
mg/dL in mononuclear cells and monocytes results in a >
two-fold elevation in reactive oxygen species [17]. High circulating 
levels of glucose can also generate glycation products from other 
important biological molecules that can cause undesirable 
functional and morphological changes [18]. In patients with type 
2 diabetes, postmeal hyperglycemia induces diabetic complications 
[19]. Therefore, the homeostatic control of blood insulin and 
glucose possibly by regulating glucose absorption from the gut 
has been implicated as an important intervention target to suppress 
abnormal metabolic changes and prevent disease development.
The GIs of various carbohydrate foods have been determined 
to develop a dietary means to control postprandial blood glucose. 
The GI is the increase in the area under the blood glucose curve 
produced by a standard amount of carbohydrate in a food, usually 
50 g, relative to the area of increase produced by the same amount 
of carbohydrate from a standard source, usually white bread or 
glucose [16]. A low GI diet and low GI food intake delays or 
reduced rapid increases in blood glucose and improves insulin 
sensitivity. Elevated postprandial glucose excursions may 
increase the risk for cardiovascular disease even in nondiabetic 
persons [20]. Additionally, high GI diets have been associated 
with the development of insulin resistance [21], cardiovascular 
disease [22-23], and type 2 diabetes [24]. Thus, it is important 
to delay the rapid increase in blood glucose to improve insulin 
response and prevent other chronic metabolic diseases.
Not only the diet itself but functional substances including 
different types of dietary fiber and monosaccharides have been 
developed to control postprandial glucose and insulin excursions. 
A recent human intervention trial using L-arabinose as a sucrase 
inhibitor indicated that a 75 g sucrose challenge supplemented 
with 4% w/w L-arabinose produces an 11% lower glucose peak 
and a 33% lower and delayed insulin peak [25]. A 23% reduction 
in the increase in the AUCi was also observed. In the present 
study, 5 g or 7.5 g xylose supplementation during a 50 g oral 
sucrose challenge effectively reduced serum glucose and insulin 
increases, and glucose absorption was delayed. D-Xylose 
possesses similar sucrase inhibitory activity as L-arabinose in 
vitro [26]. The 21.4% reduction in AUCg at 0-120 min and the 
21.3% reduction in AUCi at 0-120 min after subjects ingested 
D-xylose as observed in the present study are close to a previous 
report on the efficacy of L-arabinose [26]. An earlier study 
indicated that 80% inhibition of sucrase activity is required to 
reduce the glycemic response by 50% following treatment with 
castanosperminem, an established strong sucrase inhibitor, 
suggesting the sucrase inhibition activity may partly explain the 
reduction in the glucose response. However, no adaptive response 
to sucrose digestion was observed after a long-term (14 days) 
treatment, indicating that sucrase blockers may be safely used 
as functional substances for glucose homeostatic control. The 
present study showed no dose-response inhibitory activity, 
suggesting that there may be an optimal dose to inhibit enzyme 
activity. The manner of sucrase inhibition by D-xylose has not 538 Effects of D-xylose on postprandial glycemia
been previously reported, whereas L-arcabose selectively inhibits 
sucrose activity in an noncompetitive manner with dose- 
responsive efficacy [8]. Therefore, further kinetics studies are 
required to understand the mechanism of enzyme inhibition.
Because xylose is a sucrase inhibitor, it may be useful as a 
functional ingredient in sugar or other sucrose-rich food products 
to inhibit the blood glucose rise. In our second study we 
supplemented muffins with xylose to examine if xylose sustains 
its activity in a food matrix with large proportions of protein 
and fat. Previous studies have suggested that dietary protein 
increases insulin secretion and lowers blood glucose [11]. 
Additionally, the initial glycemic response is reduced after 
consuming a meal with higher fat content [27]. These results 
suggest that xylose supplemented in a meal with high fat or 
protein may not exert an identical effect as when supplemented 
in a sucrose solution. The results showed that a xylose- 
supplemented meal effectively reduced postprandial serum 
glucose and insulin responses; however, the extent of suppression 
was smaller than that of a xylose-supplemented solution. Xylose 
supplementation maintained its inhibitory activity up to 60 min 
for both AUCg and AUCi, and the increases in AUCg and AUCi 
at 0-120 min were reduced by 6.7% and 15.2 %, respectively. 
Previous studies have suggested that dietary protein increases 
insulin secretion and lowers blood glucose [11]. A shortened 
effectiveness may be explained by the presence of a higher 
amount of carbohydrate in test meals in study 2 compared to 
that in study 1 (65 g vs. 50 g) and/or the presence of starch 
in the test muffin, which may have less opportunity to counteract 
the sucrase inhibitor in a given time. As xylose is a sucrase 
inhibitor, it possesses no inhibitory effect on other carbohydrate 
digestive enzymes [9]. Several natural dietary substances have 
been tested for their inhibitory effects on the absorption of starch 
and sucrose in rats and pigs [28]. L-arabinose is effective for 
reducing postprandial blood glucose only after a sucrose 
challenge, but not with a rice starch challenge, whereas bean 
extract and hibiscus extract were more effective for reducing 
postprandial blood glucose after a rice starch challenge indicating 
that each substance may have different specificity to different 
carbohydrate digestive enzymes. We used a high-fat containing 
muffin as a test meal as opposed to a sucrose solution to observe 
possible changes in blood glucose responses due to high-fat 
content. Because we did not observe a significant difference 
except a loss of difference in AUCg and AUCi at one time 
interval (0-120 min), it was assumed that there was not a great 
deal of interaction between macronutrients and xylose. Further 
studies using different foods and food products are necessary 
to confirm the efficacy of xylose for postprandial glucose control.
In conclusion, the present study indicated that coconut-derived 
D-xylose favorably affected postprandial glucose and insulin 
response when used as a supplement with sucrose. As repeated 
glucose and insulin excursions are closely related to metabolic 
stress, the proper application of xylose in different sucrose-based 
products may lessen the undesired effects of sucrose.
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